NCT00846534

Brief Summary

The purpose of the investigators study is to investigate the correlation between naturally occurring chemicals, called reactive oxygen species (ROS), in the blood of human patients and the development of an abnormal heart rhythm, known as atrial fibrillation (AF). The development of atrial fibrillation is associated with increased medical problems like stroke. Many factors seem to cause the development of AF, and this rhythm occurs frequently after open heart surgery. When patients develop AF after cardiac surgery they are at increased risk for cognitive changes, infections, the development of kidney failure, and increased length of hospitalization. ROS are chemicals in blood and tissues that tend to cause microscopic blood vessel and heart damage. These chemicals occur naturally as the result of chemical reactions that occur in states of stress and inflammation, like tissue trauma and as the result of smoking. Patients who undergo cardiac surgery may have higher levels of ROS because of their underlying medical conditions. In addition, the organized tissue trauma that occurs in the setting of surgery may serve to increase ROS levels further. In turn, the higher ROS levels may put patients at even higher risk for the development of AF. The investigators believe that increased levels of ROS may help potentiate a patient's development of AF. Accordingly the investigators aim to measure ROS levels before and after surgery to see if there are particular levels that predict the development of this abnormal heart rhythm. By developing a better knowledge of the relationship between ROS and AF, the investigators hope to better understand another possible method of detecting patients who are at the highest risk of developing AF before it occurs after surgery. If these patients are better identified, this may eventually lead to medical treatment to prevent AF; and hopefully this will result in a decrease of the malicious effects that result from developing this abnormal heart rhythm.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2008

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2009

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 18, 2009

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

April 23, 2014

Status Verified

April 1, 2014

Enrollment Period

5 years

First QC Date

January 14, 2009

Last Update Submit

April 21, 2014

Conditions

Keywords

Oxidative stress markersCardiac surgeryAtrial Fibrillation

Outcome Measures

Primary Outcomes (3)

  • Baseline of oxidative stress markers prior to subjects undergoing cardiac surgery

    up to 24 hours pre-op

  • To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery

    Day 1 post-op

  • To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery

    When develop Atrial Fibrillation or upon discharge from hospital, usually within 1 week post-op

Study Arms (1)

Post operative atrial fibrillation

To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The target population of this study is all patients who will undergo cardiac surgery. There is no particular age range, but subjects less than 18 years of age will be omitted because of the rarity of AF in this population. The target number of subjects will be 100.

You may qualify if:

  • Age ≥18 years
  • Sinus rhythm at the time of enrollment as documented by ECG, telemetry, or Holter monitoring
  • Scheduled for an open heart surgery
  • Able to provide informed consent

You may not qualify if:

  • Systemic inflammatory diseases (e.g., collagen vascular diseases, infections)
  • Malignant neoplasms
  • Hyperthyroidism
  • Uncontrolled hypertension (blood pressure \> 180/100 at rest) on medications
  • An illness that might result in death within 1 year
  • Implanted devices for designed for active management of atrial arrhythmias by pacing or defibrillation
  • Current illicit drug use
  • Current ethanol abuse
  • Presence of paroxysmal, persistent, or permanent atrial fibrillation at the time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Illinois at Chicago

Chicago, Illinois, 60612, United States

Location

Advocate Christ Medical Center

Oak Lawn, Illinois, 60453, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Approximately 10- 15 ml of blood will be drawn from subjects. Blood samples will be separated into plasma and serum to measure the oxidative stress markers.

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Samuel C Dudley, MD. PhD

    University of Illinois at Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 14, 2009

First Posted

February 18, 2009

Study Start

April 1, 2008

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

April 23, 2014

Record last verified: 2014-04

Locations